~~<i id='6EF7D53973'><strike id='6EF7D53973'><tt id='6EF7D53973'><pre id='6EF7D53973'></pre></tt></strike></i>~~

Home» explore» leisure time

leisure time

author：knowledge 2025-10-01 19:20:18 Page View：7

MADRID — Merck is paying billions of dollars to partner with Daiichi Sankyo on a series of cancer drugs, underscoring the excitement around targeted chemotherapy treatments.

The deal includes a $4 billion upfront payment and an additional $1.5 billion over the next two years. Up to $16.5 billion more is on the table depending on the success of the drugs in development.

The announcement on Thursday night in the United States came on the eve of one the cancer field’s biggest annual conferences, the European Society for Medical Oncology Congress, being held this year in Madrid.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jailed Russian opposition leader Alexey Navalny gets 19 more years in prison
Next article： Wildfire smoke exposes gaps in outdoor worker protections

explore

Medical records are filled with copy

AdobeIrecentlytookcareofapatientwhosemedicalrecordsincludedmultiplenotesaboutherpastopen-heartsurger

Lifetime voting ban for felony convictions struck down in Mississippi

9:17InthisMarch10,2020,filephoto,votersworkontheirballotsinthekiosksinJackson,Miss.RogelioV.Solis/AP

Medicare details structure of new drug price negotiation program

MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

Calls for Trump's election interference trial to be televised part of long debate

8:40MediamembersprepareforthearrivalofformerPresidentDonaldTrump,whoisfacingfederalchargesinconnecti

WSS

leisure time

leisure time

comprehensive

explore

Calls for Trump's election interference trial to be televised part of long debate